Association of Clostridium difficile ribotype 078 with detectable toxin in human stool specimens

Journal of Medical Microbiology

Volumn 64, Issue 11, 2015, Pages 1341-1345

  Fairley, Derek J ^a,b   McKenna, James P ^a   Stevenson, Mike ^b   Weaver, Jeremy ^a   Gilliland, Carol ^a   Watt, Alison ^a   Coyle, Peter V ^a,b  

^a ROYAL GROUP OF HOSPITALS TRUST   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLOSTRIDIUM TOXIN; GLUTAMATE DEHYDROGENASE; BACTERIAL PROTEIN; BACTERIAL TOXIN;

ARTICLE; BACTERIUM DETECTION; BACTERIUM ISOLATE; DIARRHEA; FECES ANALYSIS; GENE LOCUS; HUMAN; IMMUNOASSAY; NONHUMAN; PEPTOCLOSTRIDIUM DIFFICILE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RIBOTYPING; FECES; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; PSEUDOMEMBRANOUS COLITIS;

BACTERIAL PROTEINS; BACTERIAL TOXINS; CLOSTRIDIUM DIFFICILE; DIARRHEA; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FECES; HUMANS; RIBOTYPING;

EID: 84948959313     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.000165     Document Type: Article

References (28)

1. Åkerlund, T., Svenungsson, B., Lagergren, A. & Burman, L. G. (2006). Correlation of disease severity with fecal toxin levels in patients with Clostridium difficile-associated diarrhea and distribution of PCR ribotypes and toxin yields in vitro of corresponding isolates. J Clin Microbiol 44, 353-358.
2. Bacci, S., Mølbak, K., Kjeldsen, M. K. & Olsen, K. E. (2011). Binary toxin and death after Clostridium difficile infection. Emerg Infect Dis 17, 976-982.
3. Clopper, C. J. & Pearson, E. S. (1934). The use of confidence or fiducial limits illustrated in the case of the binomial. Biometrika 26, 404-413.
4. Dean, A. G., Arner, T. G., Sunki, G. G., Friedman, R., Lantinga, M., Sangam, S., Zubieta, J. C., Sullivan, K. M., Brendel, K. A. & other authors (2011). Epi Info2, a database and statistics program for public health professionals. Atlanta, GA, USA: CDC.
5. Eastwood, K., Else, P., Charlett, A. & Wilcox, M. (2009). Comparison of nine commercially available Clostridium difficile toxin detection assays, a real-time PCR assay for C. difficile tcdB, and a glutamate dehydrogenase detection assay to cytotoxin testing and cytotoxigenic culture methods. J Clin Microbiol 47, 3211-3217.
6. Freeman, J., Baines, S. D., Saxton, K. & Wilcox, M. H. (2007). Effect of metronidazole on growth and toxin production by epidemic Clostridium difficile PCR ribotypes 001 and 027 in a human gut model. J Antimicrob Chemother 60, 83-91.
7. Goldenberg, S. D. & French, G. L. (2011). Lack of association of tcdC type and binary toxin status with disease severity and outcome in toxigenic Clostridium difficile. J Infect 62, 355-362.
8. Goorhuis, A., Bakker, D., Corver, J., Debast, S. B., Harmanus, C., Notermans, D. W., Bergwerff, A. A., Dekker, F. W. & Kuijper, E. J. (2008). Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078. Clin Infect Dis 47, 1162-1170.
9. Haslam, S. C., Ketley, J. M., Mitchell, T. J., Stephen, J., Burdon, D. W. & Candy, D. C. A. (1986). Growth of Clostridium difficile and production of toxins A and B in complex and defined media. J Med Microbiol 21, 293-297.
10. He, M., Miyajima, F., Roberts, P., Ellison, L., Pickard, D. J., Martin, M. J., Connor, T. R., Harris, S. R., Fairley, D. & other authors (2013). Emergence and global spread of epidemic healthcareassociated Clostridium difficile. Nat Genet 45, 109-113.
11. Hensgens, M. P. & Kuijper, E. J. (2013). Clostridium difficile infection caused by binary toxin-positive strains. Emerg Infect Dis 19, 1539-1540.
12. Jhung, M. A., Thompson, A. D., Killgore, G. E., Zukowski, W. E., Songer, G., Warny, M., Johnson, S., Gerding, D. N., McDonald, L. C. & Limbago, B. M. (2008). Toxinotype V Clostridium difficile in humans and food animals. Emerg Infect Dis 14, 1039-1045.
13. Karlsson, S., Burman, L. G. & Åkerlund, T. (1999). Suppression of toxin production in Clostridium difficile VPI 10463 by amino acids. Microbiology 145, 1683-1693.
14. Karlsson, S., Lindberg, A., Norin, E., Burman, L. G. & Åkerlund, T. (2000). Toxins, butyric acid, and other short-chain fatty acids are coordinately expressed and down-regulated by cysteine in Clostridium difficile. Infect Immun 68, 5881-5888.
15. Merrigan, M., Venugopal, A., Mallozzi, M., Roxas, B., Viswanathan, V. K., Johnson, S., Gerding, D. N. & Vedantam, G. (2010). Human hypervirulent Clostridium difficile strains exhibit increased sporulation as well as robust toxin production. J Bacteriol 192, 4904-4911.
16. Mulvey, M. R., Boyd, D. A., Gravel, D., Hutchinson, J., Kelly, S., McGeer, A., Moore, D., Simor, A., Suh, K. N. & other authors (2010). Hypervirulent Clostridium difficile strains in hospitalized patients, Canada. Emerg Infect Dis 16, 678-681.
17. O'Neill, G. L., Ogunsola, F. T., Brazier, J. S. & Duerden, B. I. (1996). Modification of a PCR ribotyping method for application as a routine typing scheme for Clostridium difficile. Anaerobe 2, 205-209.
18. Osgood, D. P., Wood, N. P. & Sperry, J. F. (1993). Nutritional aspects of cytotoxin production by Clostridium difficile. Appl Environ Microbiol 59, 3985-3988.
19. Patterson, L., Wilcox, M. H., Fawley, W. N., Verlander, N. Q., Geoghegan, L., Patel, B. C., Wyatt, T. & Smyth, B. (2012). Morbidity and mortality associated with Clostridium difficile ribotype 078: a case-case study. J Hosp Infect 82, 125-128.
20. Persson, S., Torpdahl, M. & Olsen, K. E. P. (2008). New multiplex PCR method for the detection of Clostridium difficile toxin A (tcdA) and toxin B (tcdB) and the binary toxin (cdtA/cdtB) genes applied to a Danish strain collection. Clin Microbiol Infect 14, 1057-1064.
21. Planche, T., Aghaizu, A., Holliman, R., Riley, P., Poloniecki, J., Breathnach, A. & Krishna, S. (2008). Diagnosis of Clostridium difficile infection by toxin detection kits: a systematic review. Lancet Infect Dis 8, 777-784.
22. Planche, T. D., Davies, K. A., Coen, P. G., Finney, J. M., Monahan, I. M., Morris, K. A., O'Connor, L., Oakley, S. J., Pope, C. F. & other authors (2013). Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study of C. difficile infection. Lancet Infect Dis 13, 936-945.
23. Robotham, J. & Wilcox, M. (2012). Updated Guidance on Diagnosis and Reporting of Clostridium difficile. London: Department of Health.
24. Stubbs, S. L., Brazier, J. S., O'Neill, G. L. & Duerden, B. I. (1999). PCR targeted to the 16S-23S rRNA gene intergenic spacer region of Clostridium difficile and construction of a library consisting of 116 different PCR ribotypes. J Clin Microbiol 37, 461-463.
25. UK Standards for Microbiology Investigations (2014). Processing of faeces for Clostridium difficile; Bacteriology B10, Issue no. 15. London: Standards Unit, Microbiology Services, Public Health England.
26. Walk, S. T., Micic, D., Jain, R., Lo, E. S., Trivedi, I., Liu, E. W., Almassalha, L. M., Ewing, S. A., Ring, C. & other authors (2012). Clostridium difficile ribotype does not predict severe infection. Clin Infect Dis 55, 1661-1668.
27. Warny, M., Pepin, J., Fang, A., Killgore, G., Thompson, A., Brazier, J., Frost, E. & McDonald, L. C. (2005). Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 366, 1079-1084.
28. Yamakawa, K., Kamiya, S., Meng, X. Q., Karasawa, T. & Nakamura, S. (1994). Toxin production by Clostridium difficile in a defined medium with limited amino acids. J Med Microbiol 41, 319-323.